EP2319925
Therapeutic uses of inhibitors of RTP801
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.8.2005EP published:
25.7.2018EP application number:
11153604.1
EPO information:
European Patent Register
Max expiry date:
15.8.2025
Title:
Therapeutic uses of inhibitors of RTP801
Timeline
Today
16.8.2005EP application
25.7.2018EP Publication
Owner
Name:
Quark Pharmaceuticals, Inc.Address:
6501 Dumbarton Circle, 94555, Fremont, California, US
Name:
Silence Therapeutics GmbHAddress:
Robert-Rössle-Strasse 10, 13125, Berlin, DE
Inventor
Name:
Feinstein, ElenaAddress:
Rehovot, IL
Name:
Kaufmann, JörgAddress:
Berlin, DE
Name:
Giese, KlausAddress:
Berlin, DE
Priority
Number:
601983 PDate:
17.8.2004Country:
US
Number:
604668 PDate:
25.8.2004Country:
US
Number:
609786 PDate:
14.9.2004Country:
US
Number:
638659 PDate:
22.12.2004Country:
US
Number:
664236 PDate:
22.3.2005Country:
US
Number:
688943 PDate:
8.6.2005Country:
US
Number:
04019405Date:
16.8.2004Country:
EP
Classification
Categories:
C12N 15/113, A61K 31/713, A61P 11/00, A61P 27/00